Cellular mechanism of fibril formation from serum amyloid A1 protein

EMBO Reports

Volumn 18, Issue 8, 2017, Pages 1352-1366

  Claus, Stephanie ^a   Meinhardt, Katrin ^a   Aumüller, Tobias ^a   Puscalau Girtu, Ioana ^a   Linder, Julia ^a   Haupt, Christian ^a   Walther, Paul ^a   Syrovets, Tatiana ^a   Simmet, Thomas ^a   Fändrich, Marcus ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

FRET; live cell imaging; macrophages; protein aggregation; serum amyloid A

Indexed keywords

AMYLOID PRECURSOR PROTEIN; HIGH DENSITY LIPOPROTEIN; SERUM AMYLOID A; AMYLOID; CLATHRIN; PROTEIN AGGREGATE; SAA1 PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; EXTRACELLULAR SPACE; INTERNALIZATION; LYSOSOME; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; AMYLOIDOSIS; ANIMAL; BIOLOGICAL MODEL; CELL LINE; HUMAN; MACROPHAGE; METABOLISM; PHYSIOLOGY;

AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; CELL LINE; CLATHRIN; ENDOCYTOSIS; HUMANS; MACROPHAGES; MICE; MODELS, BIOLOGICAL; PROTEIN AGGREGATES; SERUM AMYLOID A PROTEIN;

EID: 85021251349     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201643411     Document Type: Article

References (69)

1. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333–366
2. Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349: 583–596
3. Eisenberg D, Jucker M (2012) The amyloid state of proteins in human diseases. Cell 148: 1188–1203
4. Xue WF, Homans SW, Radford SE (2008) Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci USA 105: 8926–8931
5. Knowles TP, Vendruscolo M, Dobson CM (2014) The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 15: 384–396
6. Westermark G, Fändrich M, Westermark P (2015) AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol Mech Dis 10: 321–344
7. Hazenberg BP, van Gameren II, Bijzet J, Jager PL, van Rijswijk MH (2004) Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med 62: 121–128
8. Pepys MB (2006) Amyloidosis. Annu Rev Med 57: 223–241
9. Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26: 267–298
10. Röcken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440: 111–122
11. Uhlar CM, Whitehead AS (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265: 501–523
12. Röcken C, Kisilevsky R (1998) Comparison of the binding and endocytosis of high-density lipoprotein from healthy (HDL) and inflamed (HDL(SAA)) donors by murine macrophages of four different mouse strains. Virchows Arch 432: 547–555
13. Ye RD, Sun L (2015) Emerging functions of serum amyloid A in inflammation. J Leukoc Biol 98: 923–929
14. Patke S, Srinivasan S, Maheshwari R, Srivastava SK, Aguilera JJ, Colón W, Kane RS (2013) Characterization of the oligomerization and aggregation of human Serum Amyloid A. PLoS ONE 8: e64974
15. Jayaraman S, Haupt C, Gursky O (2015) Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL. J Lipid Res 56: 1531–1542
16. McCubbin WD, Kay CM, Narindrasorasak S, Kisilevsky R (1988) Circular-dichroism studies on two murine serum amyloid A proteins. Biochem J 256: 775–783
17. Smetana H (1927) The relation of the reticulo-endothelial system to the formation of amyloid. J Exp Med 45: 619–632
18. Takahashi M, Yokota T, Kawano H, Gondo T, Ishihara T, Uchino F (1989) Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages. Virchows Arch A Pathol Anat Histopathol 415: 411–419
19. Shirahama T, Cohen AS (1975) Intralysosomal formation of amyloid fibrils. Am J Pathol 81: 101–116
20. Shirahama T, Miura K, Ju ST, Kisilevsky R, Gruys E, Cohen AS (1990) Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab Invest 62: 61–68
21. Lundmark K, Vahdat Shariatpanahi A, Westermark GT (2013) Depletion of spleen macrophages delays AA amyloid development: a study performed in the rapid mouse model of AA amyloidosis. PLoS ONE 8: e79104
22. Kennel SJ, Macy S, Wooliver C, Huang Y, Richey T, Heidel E, Wall JS (2014) Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice. Amyloid 21: 45–53
23. Kluve-Beckerman B, Liepnieks JJ, Wang L, Benson MD (1999) A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am J Pathol 155: 123–133
24. Elimova E, Kisilevsky R, Szarek WA, Ancsin JB (2004) Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB J 18: 1749–1751
25. Gellermann GP, Appel TR, Tannert A, Radestock A, Hortschansky P, Schroeckh V, Leisner C, Lütkepohl T, Shtrasburg S, Röcken C et al (2005) Raft lipids as common components of human extracellular amyloid fibrils. Proc Natl Acad Sci USA 102: 6297–6302
26. Kollmer M, Meinhardt K, Haupt C, Liberta F, Wulff M, Linder J, Handl L, Heinrich L, Loos C, Schmidt M et al (2016) Electron tomography reveals the fibril structure and lipid interactions in amyloid deposits. Proc Natl Acad Sci USA 113: 5604–5609
27. Derebe MG, Zlatkov CM, Gattu S, Ruhn KA, Vaishnava S, Diehl GE, MacMillan JB, Williams NS, Hooper LV (2014) Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection. eLife 3: e03206
28. Lu J, Yu Y, Zhu I, Cheng Y, Sun PD (2014) Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc Natl Acad Sci USA 111: 5189–5194
29. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P (2014) Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21: 221–224
30. Cremades N, Cohen SI, Deas E, Abramov AY, Chen AY, Orte A, Sandal M, Clarke RW, Dunne P, Aprile FA et al (2012) Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 149: 1048–1059
31. Tosatto L, Horrocks MH, Dear AJ, Knowles TP, Dalla Serra M, Cremades N, Dobson CM, Klenerman D (2015) Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson's disease genetically related mutants. Sci Rep 5: 16696
32. Mettlen M, Pucadyil T, Ramachandran R, Schmid SL (2009) Dissecting dynamin's role in clathrin-mediated endocytosis. Biochem Soc Trans 37: 1022–1026
33. Claus S, Puscalau-Girtu I, Walther P, Syrovets T, Simmet T, Haupt C, Fändrich M (2017) Cell-to-cell transfer of SAA1 protein in a cell culture model of systemic AA amyloidosis. Sci Rep 7: 45683
34. Kluve-Beckerman B, Manaloor J, Liepnieks JJ (2001) Binding, trafficking and accumulation of serum amyloid A in peritoneal macrophages. Scand J Immunol 53: 393–400
35. Röcken C, Menard R, Bühling F, Vöckler S, Raynes J, Stix B, Krüger S, Roessner A, Kähne T (2005) Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation. Ann Rheum Dis 64: 808–815
36. Chronopoulos S, Laird DW, Ali-Khan Z (1994) Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: confocal and immunogold electron microscopic studies. J Pathol 173: 361–369
37. Okoshi T, Yamaguchi I, Ozawa D, Hasegawa K, Naiki H (2015) Endocytosed 2-microglobulin amyloid fibrils induce necrosis and apoptosis of rabbit synovial fibroblasts by disrupting endosomal/lysosomal membranes: a novel mechanism on the cytotoxicity of amyloid fibrils. PLoS ONE 10: e0139330
38. Monis GF, Schultz C, Ren R, Eberhard J, Costello C, Connors L, Skinner M, Trinkaus-Randall V (2006) Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts. Am J Pathol 169: 1939–1952
39. Bodin K, Ellmerich S, Kahan MC, Tennent GA, Loesch A, Gilbertson JA, Hutchinson WL, Mangione PP, Gallimore JR, Millar DJ et al (2010) Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature 468: 93–97
40. Loos C, Syrovets T, Musyanovych A, Mailänder V, Landfester K, Simmet T (2014) Amino-functionalized nanoparticles as inhibitors of mTOR and inducers of cell cycle arrest in leukemia cells. Biomaterials 35: 1944–1953
41. Hirakura Y, Carreras I, Sipe JD, Kagan BL (2002) Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense. Amyloid 9: 13–23
42. Butterfield SM, Lashuel HA (2010) Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. Angew Chem Int Ed Engl 49: 5628–5654
43. Friedrich RP, Tepper K, Rönicke R, Soom M, Westermann M, Reymann K, Kaether C, Fändrich M (2010) Mechanism of amyloid plaque formation suggests an intracellular basis Aβ pathogenicity. Proc Natl Acad Sci USA 107: 1942–1947
44. Harper JD, Lansbury PT Jr (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66: 385–407
45. Kimura N, Yanagisawa K (2007) Endosomal accumulation of GM1 ganglioside-bound amyloid beta-protein in neurons of aged monkey brains. NeuroReport 18: 1669–1673
46. Hu X, Crick SL, Bu G, Frieden C, Pappu RV, Lee JM (2009) Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci USA 106: 20324–20329
47. Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, Skinner M (1982) Further characterization of amyloid-enhancing factor. Lab Invest 47: 139–146
48. Glenner GG (1975) Current concepts of the formation and composition of amyloid. Ann Clin Lab Sci 5: 257–263
49. Keeling J, Teng J, Herrera GA (2004) AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells. Lab Invest 84: 1322–1338
50. Westermark P (1973) Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch A Pathol Pathol Anat 359: 1–18
51. Campistol JM, Solé M, Bombi JA, Rodriguez R, Mirapeix E, Muñoz-Gomez J, Revert OW (1992) In vitro spontaneous synthesis of beta 2-microglobulin amyloid fibrils in peripheral blood mononuclear cell culture. Am J Pathol 141: 241–247
52. Arciello A, De Marco N, Del Giudice R, Guglielmi F, Pucci P, Relini A, Monti DM, Piccoli R (2011) Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells. J Cell Mol Med 15: 2652–2663
53. Jeffrey M, McGovern G, Goodsir CM, Brown KL, Bruce ME (2000) Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy. J Pathol 191: 323–332
54. Peters PJ, Mironov A Jr, Peretz D, van Donselaar E, Leclerc E, Erpel S, DeArmond SJ, Burton DR, Williamson RA, Vey M et al (2003) Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 162: 703–717
55. Glenner GG, Ein D, Eanes ED, Bladen HA, Terry W, Page DL (1971) Creation of “amyloid” fibrils from Bence Jones proteins in vitro. Science 174: 712–714
56. Lai Z, Colón W, Kelly JW (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35: 6470–6482
57. Magde D, Wong R, Seybold PG (2002) Fluorescence quantum yields and their relation to lifetimes of rhodamine 6G and fluorescein in nine solvents: improved absolute standards for quantum yields. Photochem Photobiol 75: 327–334
58. Wang LH, Rothberg KG, Anderson RG (1993) Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123: 1107–1117
59. Lunov O, Syrovets T, Loos C, Beil J, Delacher M, Tron K, Nienhaus GU, Musyanovych A, Mailänder V, Landfester K et al (2011) Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 5: 1657–1669
60. Band AH, Chitamber SD, Bhattacharya A, Talwar GP (1986) Mechanism of phagocytosis of mycobacteria by Schwann cells and their comparison with macrophages. Int J Lepr Other Mycobact Dis 54: 292–299
61. Sandgren KJ, Wilkinson J, Miranda-Saksena M, McInerney GM, Byth-Wilson K, Robinson PJ, Cunningham AL (2010) A differential role for macropinocytosis in mediating entry of the two roms of vaccinia virus into dendritic cells. PLoS Pathog 6: e10000866
62. Hill TA, Gordon CP, McGeachie AB, Venn-Brown B, Odell LR, Chau N, Quan A, Mariana A, Sakoff JA, Chircop M et al (2009) Inhibition of dynamin mediated endocytosis by the dynoles-synthesis and functional activity of a family of indoles. J Med Chem 52: 3762–3773
63. Aoki T, Nomura R, Fujimoto T (1999) Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp Cell Res 253: 629–636
64. Oliveira CA, Kashman Y, Mantovani B (1996) Effects of latrunculin A on immunological phagocytosis and macrophage spreading-associated changes in the F-actin/G-actin content of the cells. Chem Biol Interact 100: 141–153
65. Schlegel R, Dickson RB, Willingham MC, Pastan IH (1982) Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of α2-macroglobulin. Proc Natl Acad Sci USA 79: 2291–2295
66. Sen D, Deerinck TJ, Ellisman MH, Parker I, Cahalan MD (2008) Quantum dots for tracking dendritic cells and priming an immune response in vitro and in vivo. PLoS ONE 3: e3290
67. Walther P, Ziegler A (2002) Freeze substitution of high-pressure frozen samples: the visibility of biological membranes is improved when the substitution medium contains water. J Microsc 208: 3–10
68. Gill SC, von Hippel PH (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 182: 319–326
69. Christopeit T, Hortschansky P, Schroeckh V, Gührs K, Zandomeneghi G, Fändrich M (2005) Mutagenic analysis of the nucleation propensity of oxidized Alzheimer's beta-amyloid peptide. Protein Sci 14: 2125–2131